Medical Condition News

RSS

Study examines effectiveness of active video games for improving health, fitness

A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.

5 Mar 2011

FDA accepts Lundbeck's clobazam NDA for review

Lundbeck Inc. today announced the U.S. Food and Drug Administration has accepted for review a New Drug Application for the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome in patients two years and older.

5 Mar 2011

First Lady to discuss Let's Move! initiative on childhood obesity during NLC Conference

Michelle Obama, First Lady of the United States of America, will address city leaders during the National League of Cities' 2011 Congressional City Conference on March 15th in Washington, DC. The conference sessions will focus on federal policy issues and an economic growth agenda for America's hometowns and the country.

5 Mar 2011

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

How can caregivers recognize the difference between normal age-related memory lapses and memory loss related to dementia? Prestige Assisted Living at Sierra Vista will host an educational speaker series that offers insight into memory care issues, beginning in March.

5 Mar 2011

Experts to discuss cause of sudden death on athletic playing fields

While the cause of death of the Fennville, Mich. high school basketball player is unknown, an inherited heart condition makes the top of the list for possible causes.

5 Mar 2011

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.

5 Mar 2011

Journal of Chronic Obstructive Pulmonary Disease becomes official journal of COPD Foundation

COPD: Journal of Chronic Obstructive Pulmonary Disease, the first journal dedicated to publishing a range of research on the impact of COPD, has become the official journal of the COPD Foundation.

5 Mar 2011

Scientific symposium to examine new approaches to schizophrenia drug development

Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 - Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.

5 Mar 2011

NCI renews Ariadne's license for Pathway Studio Enterprise system

Ariadne, a leader in bioinformatics software and knowledge integration, announced that National Cancer Institute has renewed their license for Pathway Studio Enterprise system that includes the ResNet Mammalian database and Ariadne MedScan text processing technology for site-wide use.

5 Mar 2011

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

The European Society for Medical Oncology, the leading professional organization for medical oncology in Europe, proudly announced that medical oncology has been included among the medical specialties covered by Directive 2005/36/EC on the recognition of professional qualifications, as announced yesterday by the Commission.

5 Mar 2011

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

The new seven-story headquarters of the David H. Koch Institute for Integrative Cancer Research at MIT, where scientists and engineers are working together to pursue new ways to treat, detect and prevent cancer, will be officially dedicated today at 4 p.m.

5 Mar 2011

Researchers use qMRI to confirm effect of CS treatment in patients with OA

A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.

5 Mar 2011

BNCT treatment proves effective in treating recurrent head, neck cancer

Biologically targeted BNCT treatment is based on producing radiation inside a tumour using boron-10 and thermal neutrons. Boron-10 is introduced into cancer cells with the help of a special carrier substance (phenylalanine), after which the tumour is irradiated with lowenergy neutrons.

5 Mar 2011

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Surgeons at University of Utah Hospital have performed the hospital's first implant of a new-generation left ventricular assist device using the HeartWare HVAD. The tiny, partial artificial heart device is being used as part of a national research study for patients with advanced heart failure who are not candidates for heart transplantation.

5 Mar 2011

Study reports highest rate of exclusive breastfeeding in El Camino Women's Hospital

The Women's Hospital at El Camino Hospital had the highest rate of exclusive and partial breastfeeding by new mothers of any hospital in the state for 2009, according to a study recently released by the UC-Davis Human Lactation Center and the California WIC Association.

5 Mar 2011

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

Golden Globe and Academy Award-nominated actor and musician Terrence Howard appears in a moving window display at Rockefeller Plaza this month, encouraging viewers to get screened for colorectal cancer as an ambassador for the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance and Stand Up To Cancer.

5 Mar 2011

Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA

The U.S. Food and Drug Administration today announced that monthly liver enzyme tests are no longer required for those taking Letairis tablets (ambrisentan), used to treat high blood pressure in the vessels that carry blood to the lungs (pulmonary arterial hypertension, or PAH).

5 Mar 2011

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center. They say the treatment - which is given just once - could potentially do the same in people at the beginning stages of the disease.

5 Mar 2011

Scientists detail role of TDP-43 in ALS pathology

Amyotrophic lateral sclerosis, known as ALS or more popularly, Lou Gehrig's disease, is a notorious neurodegenerative condition characterized by the progressive deterioration of brain and spinal cord neurons, resulting in the gradual but catastrophic loss of muscle control and ultimately, death.

5 Mar 2011

Bulow BioTech reports first ever use of Ossur POWER KNEE in cancer patient

Bulow BioTech Prosthetics is proud to announce that its patient, Lewis Branson, is among the first 3 U.S. civilians to be fitted with the Ossur POWER KNEE. The motorized knee is a "smart" prosthetic limb, which can "learn" its user's walking style and make real time adjustments based on changes in speed, stride, or terrain.

5 Mar 2011

Medical Condition News

Study examines effectiveness of active video games for improving health, fitness

FDA accepts Lundbeck's clobazam NDA for review

First Lady to discuss Let's Move! initiative on childhood obesity during NLC Conference

Prestige Assisted Living at Sierra Vista to host educational speaker series that explores memory care issues

Experts to discuss cause of sudden death on athletic playing fields

Grifols receives FDA approval for Alphanate to treat vCJD

Journal of Chronic Obstructive Pulmonary Disease becomes official journal of COPD Foundation

Scientific symposium to examine new approaches to schizophrenia drug development

NCI renews Ariadne's license for Pathway Studio Enterprise system

Medical oncology included in Directive for the sake of better cancer care in Europe: ESMO

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

Researchers use qMRI to confirm effect of CS treatment in patients with OA

BNCT treatment proves effective in treating recurrent head, neck cancer

First implantable heart transplant using new LVAD performed at University of Utah Hospital

Study reports highest rate of exclusive breastfeeding in El Camino Women's Hospital

EIF's NCCRA, SU2C to encourage people get screened for colorectal cancer

Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA

Novel gene therapy can promote removal of amyloid plaques and prevent Alzheimer's disease

Scientists detail role of TDP-43 in ALS pathology

Bulow BioTech reports first ever use of Ossur POWER KNEE in cancer patient

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Latest News